Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Company News
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Events
Directory
Editorial team
Search
Close search
Subscribe
Login
Password
Password
Remember me
Forgot password?
Close login form
Home
Company News
Company News
Alcami strengthens commercial operations with appointment of Will Isom as Vice President of Laboratory Services Sales
Alcami strengthens commercial operations with appointment of Will Isom as Vice President of Laboratory Services Sales
Alcami, a leading contract development and manufacturing organisation (CDMO), today announced the appointment of biologics industry veteran Will Isom as Vice President of...
Codis appoints Steven Facer as Chief Commercial Officer
Codis appoints Steven Facer as Chief Commercial Officer
Codis, a global contract development and manufacturing organisation (CDMO) specialising in spray drying, amorphous solid dispersions (ASDs), and advanced particle engineering,...
Qinecsa selected as technology partner for Africa’s new continent-wide medicines safety platform
Qinecsa selected as technology partner for Africa’s new continent-wide medicines safety platform
Qinecsa will help deliver a continent-wide medicines safety platform connecting safety data across Africa
Chiesi appoints David Khougazian as Group chief executive officer
Chiesi appoints David Khougazian as Group chief executive officer
David Khougazian to lead the next phase of innovation-driven growth
CordenPharma appoints Dr Jean-Luc Herbeaux as Chief Executive Officer
CordenPharma appoints Dr Jean-Luc Herbeaux as Chief Executive Officer
Leadership transition marks the next phase of growth following 12 years of transformation under Dr Michael Quirmbach
Gerresheimer names new Chairman of the Supervisory Board
Gerresheimer names new Chairman of the Supervisory Board
This year's AGM featured the election of four shareholder representatives to the Supervisory Board, including Sieger as Chairman
Scenic Biotech appoints renowned neurology drug development leader Dr. Judith Walker as Chief Medical Officer
Scenic Biotech appoints renowned neurology drug development leader Dr. Judith Walker as Chief Medical Officer
Dr. Walker joins to lead Scenic's transition into clinical development and shape its clinical strategy
Hovione appoints Stefan Doboczky as Chief Executive Officer
Hovione appoints Stefan Doboczky as Chief Executive Officer
Chairman of the board of directors Stefan Doboczky to take over operational leadership of the family-owned pharmaceutical technology and services group on April 1, 2027
Yusen Logistics appoints Gilbert den Bekker as chief commercial officer for Europe
Yusen Logistics appoints Gilbert den Bekker as chief commercial officer for Europe
Experienced commercial leader joins Yusen Logistics to support sustainable growth and strengthen commercial collaboration across Europe
Jos Vergeest appointed at Symbiosis, bringing three decades of pharmaceutical experience
Jos Vergeest appointed at Symbiosis, bringing three decades of pharmaceutical experience
Specialist pharmaceutical experience strengthens Symbiosis’ international growth ambitions
Virginie Cavalli appointed Chief Executive Officer of Seppic
Virginie Cavalli appointed Chief Executive Officer of Seppic
Seppic announces the appointment of Virginie Cavalli as Chief Executive Officer, effective September 1, 2026
Uwe Röhrhoff steps down as Interim CEO of Gerresheimer AG
Uwe Röhrhoff steps down as Interim CEO of Gerresheimer AG
Wolf Lehmann, CFO, and Achim Schalk, Member of the Management Board, will assume his duties until further notice
Symbiosis strengthens commercial team with appointment of Jay Chima
Symbiosis strengthens commercial team with appointment of Jay Chima
Symbiosis appoints Jay Chima as vice president, business development, to support growth and strengthen partnerships across the pharmaceutical and biotechnology sectors
Lonza appoints Samanta Cimitan as chief commercial officer
Lonza appoints Samanta Cimitan as chief commercial officer
Newly created role will strengthen customer engagement, commercial delivery and a harmonised go-to-market approach across One Lonza
Piramal Pharma completes acquisition of controlling stake in Yapan Bio
Piramal Pharma completes acquisition of controlling stake in Yapan Bio
Acquisition strengthens Piramal’s biologics capabilities and integrated large molecule CDMO offering
Anders Fogelberg appointed president and CEO of BICO Group AB
Anders Fogelberg appointed president and CEO of BICO Group AB
BICO appoints current Chief Commercial Officer Anders Fogelberg as President and CEO, effective September 1, 2026
Previous
1
2
(current)
3
4
5
6
7
…
217
Next
Trending Articles
Beckman Coulter Diagnostics appoints Catherine Jennings as president
Former Boston Scientific executive to lead strategic and operational priorities at global diagnostics company
Simris appoints ADC specialist as chief medical officer
Dr András Strassz joins the Swedish biotechnology company to lead clinical development as it advances its antibody-drug conjugate pipeline
EyeC expands OEM growth with new business development manager
Rigel Gallegos will lead the development of EyeC’s OEM and system integrator business
DFE Pharma appoints Peter Rose as new Chief Operating Officer
The appointment reinforces DFE Pharma’s commitment to reliable supply, scalable operations and continuous improvement
AlzeCure Pharma announces change of CEO ahead of next phase of development
AlzeCure Pharma AB (FN STO: ALZCUR), which develops small-molecule drug candidates for CNS diseases with a focus on Alzheimer’s disease and pain, announces today that CEO Martin Jönsson is stepping down and is being replaced on an interim basis by the company’s Chief Scientific Officer and co-founder, Dr. Johan Sandin. The Board of Directors will now initiate the recruitment process for a permanent CEO